Mainz Biomed N.V (MYNZ) Operating Income: 2022-2023
Historic Operating Income for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$6.6 million.
- Mainz Biomed N.V's Operating Income rose 21.44% to -$6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.6 million, marking a year-over-year decrease of 0.76%. This contributed to the annual value of -$18.7 million for FY2024, which is 29.83% up from last year.
- Mainz Biomed N.V's Operating Income amounted to -$6.6 million in Q4 2023, which was down 16.84% from -$5.6 million recorded in Q3 2023.
- Mainz Biomed N.V's Operating Income's 5-year high stood at -$5.5 million during Q3 2022, with a 5-year trough of -$8.4 million in Q4 2022.
- Its 2-year average for Operating Income is -$6.6 million, with a median of -$6.5 million in 2023.
- The largest annual percentage gain for Mainz Biomed N.V's Operating Income in the last 5 years was 21.44% (2023), contrasted with its biggest fall of 15.20% (2023).
- Quarterly analysis of 2 years shows Mainz Biomed N.V's Operating Income stood at -$8.4 million in 2022, then climbed by 21.44% to -$6.6 million in 2023.
- Its Operating Income was -$6.6 million in Q4 2023, compared to -$5.6 million in Q3 2023 and -$7.9 million in Q2 2023.